Purchases and Sales Made in Q4 2023 in Ventyx Biosciences, Inc. (VTYX)
This table provides information about the institutional ownership of Ventyx Biosciences, Inc. (VTYX) during Q4 2023. The information is specifically focused on institutions that hold shares of Ventyx Biosciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-155K- 67.9% |
$322K - $4.83M
|
73.3K
$171K
|
|
|
Feb 14, 2024
Q4 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-199K- 51.26% |
$413K - $6.19M
|
189K
$440K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-253K- 15.65% |
$526K - $7.88M
|
1.36M
$3.18M
|
|
|
Feb 13, 2024
Q4 2023
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-374K- 13.7% |
$777K - $11.7M
|
2.35M
$5.49M
|
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-388K- 39.27% |
$807K - $12.1M
|
600K
$1.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-733K- 77.97% |
$1.53M - $22.9M
|
207K
$483K
|
|
|
Dec 26, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-897K- 89.05% |
$1.87M - $28M
|
110K
$257K
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.69M- 98.94% |
$3.51M - $52.7M
|
18.1K
$42.1K
|
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-3.62M- 94.69% |
$7.54M - $113M
|
203K
$474K
|